Courage Capital Management’s Editas Medicine EDIT Stock Holding History

Courage Capital Management’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-9,000	Closed	-$239K	–	38
2021 Q4	$239K	Hold	9,000	–	–	0.16%	37
2021 Q3	$370K	Hold	9,000	–	–	0.2%	36
2021 Q2	$510K	Buy	9,000 +4,000	+80%	+$148K	0.3%	32
2021 Q1	$210K	Hold	5,000	–	–	0.15%	38
2020 Q4	$351K	Buy	+5,000	New	+$205K	0.35%	29
2018 Q3	–	Sell	-8,400	Closed	-$301K	–	27
2018 Q2	$301K	Buy	8,400 +2,100	+33%	+$74.4K	0.22%	22
2018 Q1	$209K	Hold	6,300	–	–	0.16%	27
2017 Q4	$194K	Buy	+6,300	New	+$159K	0.14%	21

Other funds holding EDIT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Courage Capital Management's EDIT Position: Q1 2022 in Review

Courage Capital Management sold out of Editas Medicine (EDIT) in Q1 2022, closing a stake of 9,000 shares — an estimated $239K sold.

Courage Capital Management first reported a position in EDIT in Q4 2017 and held it in 8 quarters. The position peaked at $510K in Q2 2021. 257 funds tracked by Wall St. Rank hold EDIT as of Q1 2022.

Courage Capital Management reported no remaining Editas Medicine position as of Q1 2022 after selling out during the quarter.
Courage Capital Management sold 9,000 Editas Medicine shares in Q1 2022, an estimated $239K.
Courage Capital Management first reported a position in Editas Medicine in Q4 2017 and held it in 8 quarters.
Courage Capital Management's Editas Medicine position peaked at $510K in Q2 2021.
257 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2022.

Based on Courage Capital Management's 13F filing for Q1 2022, filed 16 May 2022.